Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort
Authors:
- Chih-Feng WuCWChih-Feng Wu
- Feng-Yu SungFSFeng-Yu Sung
- Chun-Jen LiuCLChun-Jen Liu
- Chi-Jung HuangCHChi-Jung Huang
- Keh-Sung TsaiKTKeh-Sung Tsai
- Ming-Whei YuMYMing-Whei Yu
Open Access
- 3 April 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 32 (6) , 876-881
Abstract
This study aimed to investigate the association of fasting insulin and glucose levels with hepatocellular carcinoma (HCC) risk in a case–cohort study within a cohort (1989–2006) of 2903 male government employees chronically infected with hepatitis B virus (HBV) in Taiwan. Insulin, glucose and HBV-related factors were assayed in baseline plasma among 124 HCC cases and a random subcohort of 1084 of the total cohort. After adjustment for demographics and HBV-related factors, including viral load and genotype, the HCC risk was higher for the highest [>6.10 μU/ml, hazard ratio (HR) = 2.36, 95% confidence interval (CI): 1.43–3.90] and lowest (P for trend <0.0001). The effect of higher insulin on HCC risk remained after adjustment for other metabolic factors, and was fairly consistent across strata of age, body mass index, and HBV genotypic variants. However, it was more profound among those with viral load 6.10 μU/ml, HR = 6.15, 95% CI: 2.48–15.22). Higher insulin was also associated with an increased risk for cirrhosis diagnosed by ultrasonography and elevated alanine aminotransferase. No association with either cirrhosis or HCC was noted for glucose or diabetes after adjusting for insulin. In conclusion, elevated insulin levels are an independent risk factor for HCC among HBV carriers, especially for those with lower viral load.Keywords
This publication has 41 references indexed in Scilit:
- The Clinical Presentation of Chronic Hepatitis B Virus Infection in Asian AmericansJournal of Clinical Gastroenterology, 2010
- Diabetes increases the risk of chronic liver disease and hepatocellular carcinomaGastroenterology, 2004
- Global control of hepatitis B virus infectionThe Lancet Infectious Diseases, 2002
- Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2002
- Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the EvidenceThe Journal of Nutrition, 2001
- Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in menInternational Journal of Cancer, 2000
- Excess Risk of Primary Liver Cancer in Patients With Diabetes MellitusJNCI: Journal of the National Cancer Institute, 1996
- Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population studyHepatology, 1996
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985
- Role of Hormones in the Growth and Regression of Human Breast Cancer Cells (MCF-7) Transplanted Into Athymic Nude Mice2JNCI: Journal of the National Cancer Institute, 1981